117 related articles for article (PubMed ID: 23800652)
1. Predictors of agreement between general practitioner detection of dementia and the revised Cambridge Cognitive Assessment (CAMCOG-R).
Pond CD; Mate KE; Phillips J; Stocks NP; Magin PJ; Weaver N; Brodaty H
Int Psychogeriatr; 2013 Oct; 25(10):1639-47. PubMed ID: 23800652
[TBL] [Abstract][Full Text] [Related]
2. Is the Cambridge Cognitive Examination - revised a good tool for detection of dementia in illiterate Brazilian older adults?
Paradela EM; Lourenço RA
Geriatr Gerontol Int; 2014 Oct; 14(4):763-8. PubMed ID: 24666650
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and disclosure of a memory problem is associated with quality of life in community based older Australians with dementia.
Mate KE; Pond CD; Magin PJ; Goode SM; McElduff P; Stocks NP
Int Psychogeriatr; 2012 Dec; 24(12):1962-71. PubMed ID: 22874650
[TBL] [Abstract][Full Text] [Related]
4. Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R).
Athey RJ; Porter RW; Walker RW
Age Ageing; 2005 May; 34(3):268-73. PubMed ID: 15863411
[TBL] [Abstract][Full Text] [Related]
5. The Cambridge Cognitive Examination (CAMCOG): validation of the Hebrew version in elderly demented patients.
Heinik J; Werner P; Mendel A; Raikher B; Bleich A
Int J Geriatr Psychiatry; 1999 Dec; 14(12):1006-13. PubMed ID: 10607967
[TBL] [Abstract][Full Text] [Related]
6. Predicting risk of 2-year incident dementia using the CAMCOG total and subscale scores.
Restaino M; Matthews FE; Minett T; Albanese E; Brayne C; Stephan BC
Age Ageing; 2013 Sep; 42(5):649-53. PubMed ID: 23872637
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of the Brazilian version of the informant questionnaire on cognitive decline in the elderly at screening for dementia in community-dwelling elderly participants: findings from FIBRA-RJ study.
Lourenço RA; Sanchez MA
J Geriatr Psychiatry Neurol; 2014 Sep; 27(3):212-9. PubMed ID: 24614204
[TBL] [Abstract][Full Text] [Related]
8. A depressive endophenotype of poorer cognition among cognitively healthy community-dwelling adults: results from the Western Australia memory study.
Johnson LA; Sohrabi HR; Hall JR; Kevin T; Edwards M; O'Bryant SE; Martins RN
Int J Geriatr Psychiatry; 2015 Aug; 30(8):881-6. PubMed ID: 25394326
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of the GPCOG, a screening tool for cognitive impairment.
Brodaty H; Kemp NM; Low LF
Int J Geriatr Psychiatry; 2004 Sep; 19(9):870-4. PubMed ID: 15352145
[TBL] [Abstract][Full Text] [Related]
10. CAMCOG as a screening instrument for dementia: the Odense study. Cambridge Cognitive Examination.
Lolk A; Nielsen H; Andersen K; Andersen J; Kragh-Sørensen P
Acta Psychiatr Scand; 2000 Nov; 102(5):331-5. PubMed ID: 11098803
[TBL] [Abstract][Full Text] [Related]
11. Depression and Cognitive Impairment in Institutionalized Older Adults.
Camacho-Conde JA; Galán-López JM
Dement Geriatr Cogn Disord; 2020; 49(1):107-120. PubMed ID: 32634807
[TBL] [Abstract][Full Text] [Related]
12. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of cognitive decline in Parkinson's disease using the Cambridge Cognitive Assessment (Revised) (CAMCOG-R).
Athey RJ; Walker RW
Int J Geriatr Psychiatry; 2006 Oct; 21(10):977-82. PubMed ID: 16955442
[TBL] [Abstract][Full Text] [Related]
14. [The Cambridge Cognitive Examination as a tool for detection of dementia].
Lozano-Gallego M; Vilalta-Franch J; Llinàs-Reglà J; López-Pousa S
Rev Neurol; 1999 Feb 16-28; 28(4):348-52. PubMed ID: 10714310
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional community study of serum iron measures and cognitive status in older adults.
Milward EA; Bruce DG; Knuiman MW; Divitini ML; Cole M; Inderjeeth CA; Clarnette RM; Maier G; Jablensky A; Olynyk JK
J Alzheimers Dis; 2010; 20(2):617-23. PubMed ID: 20182059
[TBL] [Abstract][Full Text] [Related]
16. The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test.
Hobson P; Meara J
Age Ageing; 1999 Jan; 28(1):39-43. PubMed ID: 10203203
[TBL] [Abstract][Full Text] [Related]
17. Apart from nihilism and stigma: what influences general practitioners' accuracy in identifying incident dementia?
Pentzek M; Wollny A; Wiese B; Jessen F; Haller F; Maier W; Riedel-Heller SG; Angermeyer MC; Bickel H; Mösch E; Weyerer S; Werle J; Bachmann C; Zimmermann T; van den Bussche H; Abholz HH; Fuchs A;
Am J Geriatr Psychiatry; 2009 Nov; 17(11):965-75. PubMed ID: 20104054
[TBL] [Abstract][Full Text] [Related]
18. Cambridge Cognitive Examination and Hachinski Ischemic Score as predictors of MRI confirmed pathology in dementia: A cross-sectional study.
Titheradge D; Isaac M; Bremner S; Tabet N
Int J Clin Pract; 2020 Feb; 74(2):e13446. PubMed ID: 31750588
[TBL] [Abstract][Full Text] [Related]
19. Normative scores of the Cambridge Cognitive Examination-Revised in healthy Spanish population.
Pereiro AX; Ramos-Lema S; Juncos-Rabadán O; Facal D; Lojo-Seoane C
Psicothema; 2015; 27(1):32-9. PubMed ID: 25633767
[TBL] [Abstract][Full Text] [Related]
20. Measuring impairments in memory and executive function in older people using the Revised Cambridge Cognitive Examination.
Kessels RP; Mimpen G; Melis R; Rikkert MG
Am J Geriatr Psychiatry; 2009 Sep; 17(9):793-801. PubMed ID: 19700951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
